ClinicalTrials.gg
CompletedNCT07517926Updated Oct 23, 2026

Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms

An interventional study of Chewing Gum and Cold Water Gargle in Sore Throat, Dysphagia and Patient Satisfaction, sponsored by Ankara University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Primary conditionDeglutition DisordersRegistry: PharyngitisReclassifiedWhy we changed it
Registry
Pharyngitis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Deglutition Disorders
Why
  1. The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Deglutition Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Ankara University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Sep 2025, registered Apr 2026).
Updated Oct 23, 2026Now CompletedPrimary outcomes revised+7 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the effects of chewing gum and gargling with cold water on common post-bronchoscopy symptoms, such as sore throat and difficulty swallowing (dysphagia). Bronchoscopy is a procedure that can cause temporary throat discomfort. In this randomized controlled trial, patients will be divided into groups to receive either chewing gum, cold water gargle, or standard care. The researchers will then measure and compare patient satisfaction levels and the severity of throat symptoms to determine if these simple interventions can improve patient comfort after the procedure.

Read the detailed description

Study Implementation and Procedures

All patients in the intervention and control groups will be informed about the study's purpose. Patients undergoing bronchoscopy receive routine verbal education from bronchoscopy nurses. In addition to routine education, the intervention groups will receive specific instructions from the researchers. Patients will be blinded to their randomization status and study hypotheses. However, researchers will not be blinded as they will perform the interventions. The chewing gum and cold water gargle procedures will be explained and demonstrated to the intervention groups during face-to-face interviews.

Chewing Gum Procedure All patients will follow the hospital's standard pre-procedure fasting protocol (8 hours of fasting). A researcher will be responsible for supervising the chewing gum procedure. Patients in this group will be asked to chew a commercially available sugar-free gum containing xylitol for 15 minutes immediately before the procedure. After 15 minutes of chewing, patients will discard the gum. The researcher will ensure the gum is removed before the patient is admitted for bronchoscopy. Patients will be strictly instructed not to swallow the gum.

Cold Water Gargle Procedure Patients in this group will perform a cold water gargle under the supervision of a researcher 15 minutes before the procedure. Patients will be instructed not to swallow the water. The researcher will prepare the water at a temperature between 8-12°C (refrigerator coldness). Patients will gargle twice for 30 seconds each, approximately 15 minutes before the procedure.

Control Group The control group will receive standard hospital procedures without any additional intervention.

Data Collection and Evaluation Sore throat, difficulty swallowing (dysphagia), and patient satisfaction levels will be evaluated before the procedure, and at the 2nd and 24th hours post-procedure. The 24-hour evaluation will be conducted via telephone by the research team.

02

Conditions studied

  • Sore Throat
  • Dysphagia
  • Patient Satisfaction
  • Bronchoscopy

Browse trials for

Keywords

  • Bronchoscopy
  • Sore Throat
  • Dysphagia
  • Chewing Gum
  • Cold Water Gargle
  • Nursing Care
03

In context

Deglutition Disorders Reclassified

871 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.

This study's enrollment of 108 is above the median of 60 across 578 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

Ankara University is the lead sponsor of 320 studies on the registry; 64 are open to participants now.

Compared within Deglutition Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Pharyngitis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

The criteria were revised on the registry on Oct 20, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

Being 18 years of age or older Being scheduled for a non-emergency bronchoscopy Having normal speech and swallowing functions Being conscious and able to communicate Agreeing to participate and providing written Exclusion Criteria

Gastroesophageal reflux Signs of active infection in the oral or throat region Use of non-steroidal anti-inflammatory drugs (NSAIDs) Any drug allergy therapy during the week before the procedure Anatomical or functional impairment that prevents chewing gum or gargling Undergoing emergency interventional bronchoscopy

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (actual)

Study arms

  • Experimental
    Chewing Gum Group

    Patients in this group will chew sugar-free xylitol gum for 15 minutes immediately before bronchoscopy.

    Behavioral: Chewing Gum

  • Experimental
    Cold Water Gargle Group

    Patients in this group will gargle with cold water (8-12°C) twice for 30 seconds each, 15 minutes before bronchoscopy.

    Behavioral: Cold Water Gargle

  • No intervention
    Control Group

    Patients in this group will receive standard care without additional interventions.

Interventions

  • BehavioralChewing Gum

    Patients will chew sugar-free xylitol gum for 15 minutes immediately before the bronchoscopy procedure

  • BehavioralCold Water Gargle

    Patients will gargle with cold water (8-12°C) twice for 30 seconds each, 15 minutes before the bronchoscopy procedure.

06

What researchers measure

Primary outcomes

  1. Severity of Post-Bronchoscopy Sore Throat

    Sore throat severity was assessed using a Visual Analog Scale (VAS), where 0 represents "no pain" and 10 represents "very severe pain." Higher scores indicate greater pain severity.

    Time frame: Baseline (pre-procedure), 2nd hour, and 24th hour post-procedure.

Secondary outcomes

  1. Severity of Post-Bronchoscopy Dysphagia

    Dysphagia severity was assessed using the Eating Assessment Tool-10 (EAT-10), a 10-item scale with total scores ranging from 0 to 40. Higher scores indicate more severe dysphagia; a score of 3 or higher is considered abnormal.

    Time frame: Baseline (pre-procedure), 2nd hour, and 24th hour post-procedure.

  2. Patient Satisfaction Level

    Patient satisfaction was assessed using the Patient Satisfaction Questionnaire Short Form (PSQ-18), which includes seven subscales: general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with the doctor, and accessibility and convenience.

    Time frame: Before bronchoscopy and 24 hours after the procedure.

07

Study locations

1 site
  • Gulhane Training and Research Hospital
    Ankara, Ankara 06010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect participant privacy and confidentiality.

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 20, 2026
Sites
1 site added, 1 site removed
Show site
  • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
Show 1 removed
  • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
Oct 20, 2026
Start date
Nov 10, 2025→Sep 15, 2025
Oct 20, 2026
Primary completion
May 11, 2026→Feb 20, 2026 (actual)
Oct 20, 2026
Study completion
May 11, 2026→Feb 27, 2026 (actual)
Oct 20, 2026
Enrollment
100 (estimated)→108 (actual)
Oct 20, 2026
Eligibility
5 inclusion criteria removed; 7 exclusion criteria removed; 3 criteria added
What changed in the criteria
  • AddedInclusion Criteria
  • AddedBeing 18 years of age or older Being scheduled for a non-emergency bronchoscopy Having normal speech and swallowing functions Being conscious and able to communicate Agreeing to participate and providing written informed consent Exclusion Criteria
  • AddedGastroesophageal reflux Signs of active infection in the oral or throat region Use of non-steroidal anti-inflammatory drugs (NSAIDs) Any drug allergy Steroid therapy during the week before the procedure Anatomical or functional impairment that prevents chewing gum or gargling Undergoing emergency interventional bronchoscopy
Inclusion criteria
  • Removed• Being 18 years of age or older
  • RemovedHaving a scheduled diagnostic bronchoscopy
  • RemovedHaving normal speech and swallowing functions
  • RemovedBeing conscious and able to communicate
  • RemovedVolunteering to participate in the study
Exclusion criteria
  • Removed• Complications during bronchoscopy
  • RemovedGastroesophageal reflux
  • RemovedUse of non-steroidal anti-inflammatory drugs
  • RemovedReceiving steroid treatment within 1 week prior to the procedure
  • RemovedActive infection or disease in the mouth or throat area
  • RemovedHistory of allergy or intolerance to the procedure
  • RemovedPrevious anatomical or functional impediment to chewing gum or gargling
Oct 20, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionSeverity of Post-Bronchoscopy Sore Throat: how it is measured was reworded
Oct 23, 2026
Secondary outcomes
Revised in 2 updates
What changed on Oct 20, 2026
  • Time framePatient Satisfaction Level2nd hour and 24th hour post-procedure. → Before bronchoscopy and 24 hours after the procedure.
  • DescriptionPatient Satisfaction Level: how it is measured was reworded
What changed on Oct 23, 2026
  • DescriptionSeverity of Post-Bronchoscopy Dysphagia: how it is measured was reworded
across 2 updates, Oct 20, 2026 – Oct 23, 2026
Show all 2 updates
  1. Oct 23, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionSeverity of Post-Bronchoscopy Sore Throat: how it is measured was reworded
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionSeverity of Post-Bronchoscopy Dysphagia: how it is measured was reworded
  2. Oct 20, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
    Show 1 removed
    • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
    Start date Nov 10, 2025→Sep 15, 2025
    Primary completion May 11, 2026→Feb 20, 2026 (now actual)
    Study completion May 11, 2026→Feb 27, 2026 (now actual)
    Enrollment 100 (estimated)→108 (actual)
    Eligibility 5 inclusion criteria removed; 7 exclusion criteria removed; 3 criteria added
    What changed in the criteria
    • AddedInclusion Criteria
    • AddedBeing 18 years of age or older Being scheduled for a non-emergency bronchoscopy Having normal speech and swallowing functions Being conscious and able to communicate Agreeing to participate and providing written informed consent Exclusion Criteria
    • AddedGastroesophageal reflux Signs of active infection in the oral or throat region Use of non-steroidal anti-inflammatory drugs (NSAIDs) Any drug allergy Steroid therapy during the week before the procedure Anatomical or functional impairment that prevents chewing gum or gargling Undergoing emergency interventional bronchoscopy
    Inclusion criteria
    • Removed• Being 18 years of age or older
    • RemovedHaving a scheduled diagnostic bronchoscopy
    • RemovedHaving normal speech and swallowing functions
    • RemovedBeing conscious and able to communicate
    • RemovedVolunteering to participate in the study
    Exclusion criteria
    • Removed• Complications during bronchoscopy
    • RemovedGastroesophageal reflux
    • RemovedUse of non-steroidal anti-inflammatory drugs
    • RemovedReceiving steroid treatment within 1 week prior to the procedure
    • RemovedActive infection or disease in the mouth or throat area
    • RemovedHistory of allergy or intolerance to the procedure
    • RemovedPrevious anatomical or functional impediment to chewing gum or gargling
    Secondary outcomes 1 time frame changed, 1 description edited
    What changed in the outcomes
    • Time framePatient Satisfaction Level2nd hour and 24th hour post-procedure. → Before bronchoscopy and 24 hours after the procedure.
    • DescriptionPatient Satisfaction Level: how it is measured was reworded
    + 4 other changes: identifiers, verification date, design details and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07517926
Lead sponsor
Ankara University
Responsible party
Neriman Yükseltürk Simşek (Assistant Professor, Ankara University) — Principal investigator
First posted
Apr 8, 2026
Start date
Sep 15, 2025
Primary completion
Feb 20, 2026
Completion
Feb 27, 2026
Last update
Oct 23, 2026

Study contacts

neriman yükseltürk şimşek
principal investigator · ankara u

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion